MultiCell Technologies Competitors and Similar CompaniesClear all
MultiCell Technologies's competitors and similar companies include Alexion Pharmaceuticals.
 MultiCell Technologies MultiCell Technologies, Inc. is a clinical-stage biopharmaceutical company developing novel therapeutics and discovery tools that address unmet medical needs for the treatment of neurological disorders, hepatic disease and cancer. |  Alexion Pharmaceuticals Alexion (also known as Alexion, AstraZeneca Rare Disease) is a biopharmaceutical company engaged in therapies for rare diseases. | |
Founding Date | Founding Date 1962 | Founding Date 1992 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Woonsocket, US HQ | Locations Boston, US HQ Frenchs Forest, AU Wien, AT Elsene, BE São Paulo, BR Vaughan, CA Shanghai, CN see more |
Employees | Employees 2 | Employees 10,6006% increase |
Valuation ($) | Valuation ($) 1 m | Valuation ($) 40.3 b |
Financial | ||
Revenue (est.) | Revenue (est.) $49.3k (FY, 2014) | Revenue (est.) $6.1b (FY, 2020) |
Net income | Net income ($528.8k) (FY, 2014) | Net income $603.4m (FY, 2020) |
For sources of this data, please see the company profile
View Company Profiles
Alexion Pharmaceuticals
HQ
Boston, US
Employees
10,600↑ 6% increase
Alexion (also known as Alexion, AstraZeneca Rare Disease) is a biopharmaceutical company engaged in therapies for rare diseases.
View company